Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | NPC1 | O15118 | 5/20 | 0.73 |
| ▸ | RAB9A | P51151 | 4/20 | 0.73 |
| ▸ | HTT | P42858 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.73 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.73 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.73 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.73 |
| ▸ | PDE4A | P27815 | 1/20 | 0.73 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.73 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11048619 | 1.00 | MEN1 (0.76) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL5650525 | 0.91 | MAOA (0.67) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL11054644 | 0.91 | CNR1 (0.74) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL4105004 | 0.91 | CNR1 (0.74) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL11055930 | 0.89 | CNR1 (0.70) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL14758356 | 0.89 | MEN1 (0.75) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL3026575 | 0.89 | RAB9A (0.70) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL17119070 | 0.89 | RAB9A (0.70) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL4548119 | 0.89 | CNR1 (0.70) | MEN1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL14107061 | 0.89 | GRIK1 (0.64) | MEN1KMT2AALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1549730-A1 | DISINFECTANT CLEANING COMPOSITIONS | Reckitt Benckiser Inc. (US) | 2005-07-06 | — | — | EP | claimed |
| WO-2004035723-A1 | DISINFECTANT CLEANING COMPOSITIONS | RECKITT BENCKISER INC (US) | 2004-04-29 | — | — | WO | claimed |
| EP-4734912-A2 | HIGH SEPARATION DUAL PHASE EYE MAKE-UP REMOVER | Mary Kay, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026087386-A1 | ROSIN DIESTER COMPOUNDS AND USES THEREOF | FIRMENICH SA (CH) | 2026-04-30 | — | — | WO | disclosed |
| EP-4731171-A2 | MINERAL FACIAL SUNSCREEN | Mary Kay, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4724153-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | Mary Kay, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260090980-A1 | COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME | MARY KAY INC. (US) | 2026-04-02 | — | — | US | disclosed |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | MARY KAY INC. (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2025264660-A1 | COSMETIC COMPOSITION COMPRISING CAFFEINE AND MELATONIN | MARY KAY INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| US-20250387310-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | FIRMENICH INCORPORATED (US) | 2025-12-25 | — | — | US | disclosed |
| US-20250381117-A1 | COSMETIC COMPOSITION COMPRISING CAFFEINE AND MELATONIN | MARY KAY INC. (US) | 2025-12-18 | — | — | US | disclosed |
| EP-0052341-B1 | OROTIC ACID DERIVATIVES AND THEIR USE AS AGRICULTURAL CHEMICALS | UBE INDUSTRIES, LTD. (JP) | 1985-05-29 | — | — | EP | disclosed |
| US-4480110-A | FROM SUBSTITUTED UREAS AND ALCOHOL | BAYER AKTIENGESELLSCHAFT (DE) | 1984-10-30 | — | — | US | disclosed |
| US-4444863-A | UREA COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1984-04-24 | — | — | US | disclosed |
| US-4400508-A | AGRICULTURE; PLANT DISEASES; ANTISEPTICS | UBE INDUSTRIES, LTD. (JP) | 1983-08-23 | — | — | US | disclosed |
| US-4399280-A | MOTHPROOFING, PROTECTION OF KERATINOUS MATERIAL | CIBA-GEIGY CORPORATION (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0052341-A1 | Orotic acid derivatives and their use as agricultural chemicals | UBE INDUSTRIES, LTD. (JP) | 1982-05-26 | — | — | EP | disclosed |
| US-4283444-A | MOTHPROOFING WOOLS, FURS, SKINS | CIBA-GEIGY CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4275215-A | QUATERNARY AMMONIUM OR PHOSPHONIUM SALTS CATALYZE REACTION OF HYPOHALITE AND A DIPHENYL UREA | DOW CHEMICAL COMPANY LIMITED (GB) | 1981-06-23 | — | — | US | disclosed |
| EP-0004733-A2 | Diaryl substituted pyrazoline carboxanilides, processes for preparing them, insecticidal compositions and uses thereof, and intermediates therefor | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090980-A1 | COSMETIC COMPOSITIONS AND METHODS OF USING THE SAME | CUTA, DSG1, HIRA | MEN1 901/4885KMT2A 2972/4885ALDH1A1 3767/4885 |
| US-20250387310-A1 | COMPOSITIONS THAT ENHANCE THE COOLING EFFECT | TAS2R30, TAS2R1, TAS2R20 | MEN1 2514/4885KMT2A 2006/4885ALDH1A1 540/4885 |
| US-20260083659-A1 | SUNSCREEN COMPOSITIONS AND METHODS OF USE | CUTA, TYR, SUN2 | MEN1 4259/4885KMT2A 3464/4885ALDH1A1 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.